CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) saw a significant drop in short interest in the month of May. As of May 29th, there was short interest totaling 582 shares, a drop of 36.3% from the May 14th total of 913 shares. Based on an average daily volume of 3,299 shares, the short-interest ratio is currently 0.2 days.
CSPC Pharmaceutical Group Stock Down 2.2%
OTCMKTS:CSPCY opened at C$3.62 on Wednesday. The firm’s 50 day moving average is C$4.12 and its two-hundred day moving average is C$4.45. CSPC Pharmaceutical Group has a fifty-two week low of C$3.45 and a fifty-two week high of C$5.83.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
Read More
- Five stocks we like better than CSPC Pharmaceutical Group
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
